UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label trial

The lancet oncology, 2013-09, Vol.14 (10), p.1020-1026

2013

Volltextzugriff (PDF)

Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial

The Lancet (British edition), 2009-10, Vol.374 (9698), p.1331-1338

2009

Volltextzugriff (PDF)

Indoleamine 2,3-Dioxygenase Serves as a Marker of Poor Prognosis in Gene Expression Profiles of Serous Ovarian Cancer Cells

Clinical cancer research, 2005-08, Vol.11 (16), p.6030-6039

2005

Volltextzugriff (PDF)

Adjuvant therapy after radical surgery for stage IB-IIB cervical adenocarcinoma with risk factors

Japanese journal of clinical oncology, 2017-01, Vol.47 (1), p.32-38

2017

Volltextzugriff (PDF)

Readministration of Platinum Agents in Recurrent Ovarian Cancer Patients Who Developed Hypersensitivity Reactions to Carboplatin

In vivo (Athens), 2019-11, Vol.33 (6), p.2045-2050

2019

Volltextzugriff (PDF)

Retrospective analysis of sites of recurrence in stage I epithelial ovarian cancer

Journal of Gynecologic Oncology, 2018, 29(3), , pp.1-11

2018

Volltextzugriff (PDF)

Establishment and characterization of a clear cell carcinoma cell line, designated NOCC, derived from human ovary

Human cell : official journal of Human Cell Research Society, 2016-10, Vol.29 (4), p.188-196

2016

Volltextzugriff (PDF)

Possible involvement of glycolipids in anticancer drug resistance of human ovarian serous carcinoma-derived cells

Journal of biochemistry (Tokyo), 2012-12, Vol.152 (6), p.587-594

2012

Volltextzugriff (PDF)

Side population is increased in paclitaxel-resistant ovarian cancer cell lines regardless of resistance to cisplatin

Gynecologic oncology, 2011-05, Vol.121 (2), p.390-394

2011

Volltextzugriff (PDF)

Alpha-fetoprotein (AFP)-producing ovarian tumor in an elderly woman

International journal of clinical oncology, 2009-02, Vol.14 (1), p.70-73

2009

Volltextzugriff (PDF)

Pathology-oriented treatment strategy of malignant ovarian tumor in pregnant women: analysis of 41 cases in Japan

International journal of clinical oncology, 2014-12, Vol.19 (6), p.1074-1079

2014

Volltextzugriff (PDF)

Analysis of prognostic factors for patients with leiomyoma treated with uterine arterial embolization

American journal of obstetrics and gynecology, 2008-03, Vol.198 (3), p.270.e1-270.e6

2008

Volltextzugriff (PDF)

Randomized Phase III Trial of Irinotecan Plus Cisplatin Compared With Paclitaxel Plus Carboplatin As First-Line Chemotherapy for Ovarian Clear Cell Carcinoma: JGOG3017/GCIG Trial

Journal of clinical oncology, 2016-08, Vol.34 (24), p.2881-2887

2016

Volltextzugriff (PDF)

Characterization of two independent, exposure-time dependent paclitaxel-resistant human ovarian carcinoma cell lines

Human cell : official journal of Human Cell Research Society, 2010-11, Vol.23 (4), p.156-163

2010

Volltextzugriff (PDF)

Small cell carcinoma of the ovary: clinical and biological study

International journal of clinical oncology, 2008-04, Vol.13 (2), p.161-165

2008

Volltextzugriff (PDF)

Differential regulation of the cytotoxicity activity of paclitaxel by orobol and platelet derived growth factor in human ovarian carcinoma cells

Oncology reports, 2007-07, Vol.18 (1), p.195-201

2007

Volltextzugriff (PDF)

Favourable Prognosis with Modified Dosing of Docetaxel and Cisplatin in Japanese Patients with Ovarian Cancer

Anticancer research, 2009-02, Vol.29 (2), p.561-566

2009

Volltextzugriff (PDF)

Mithramycin Represses MDR1 Gene Expression in Vitro, Modulating Multidrug Resistance

Biological and Pharmaceutical Bulletin, 2000/08/01, Vol.23(8), pp.926-929

2000

Volltextzugriff (PDF)

Two cases of epidural anesthesia‐associated postoperative decubitus

The journal of obstetrics and gynaecology research, 2008-08, Vol.34 (4pt2), p.763-766

2008

Volltextzugriff (PDF)

Primary chemotherapy-associated effect of second-line chemotherapy on survival of patients with advanced ovarian cancer

International journal of clinical oncology, 2006-06, Vol.11 (3), p.236-242

2006

Volltextzugriff (PDF)

Malignant Struma Ovarii With a Predominant Component of Anaplastic Carcinoma

International journal of gynecological pathology, 2016-07, Vol.35 (4), p.357-361

2016

Volltextzugriff (PDF)

Progression-free survival by local investigator versus independent central review: Comparative analysis of the AGO-OVAR16 Trial

Gynecologic oncology, 2015-01, Vol.136 (1), p.37-42

2015

Volltextzugriff (PDF)

A Novel Gene, CRR9, Which Was Up-Regulated in CDDP-Resistant Ovarian Tumor Cell Line, Was Associated with Apoptosis

Biochemical and biophysical research communications, 2001-02, Vol.280 (4), p.1148-1154

2001

Volltextzugriff (PDF)

Short-Term Serum Deprivation Confers Sensitivity to Taxanes in Platinum-Resistant Human Ovarian Cancer Cells

International journal of gynecological cancer, 2011-12, Vol.21 (9), p.1547-1554

2011

Volltextzugriff (PDF)

Success rate and safety of tumor debulking with diaphragmatic surgery for advanced epithelial ovarian cancer and peritoneal cancer

Archives of gynecology and obstetrics, 2015-03, Vol.291 (3), p.641-646

2015

Volltextzugriff (PDF)

1 – 25 von 57

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(39)

Publikationsform

Artikel
(57)

Sprache

Englisch
(46)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

Female
(49)
Life Sciences & Biomedicine
(42)
Science & Technology
(42)
Oncology
(24)
Ovarian Neoplasms - Pathology
(23)
Ovarian Neoplasms - Drug Therapy
(22)
Biological And Medical Sciences
(18)
Medical Sciences
(17)
Adult
(16)
Middle Aged
(16)
Ovarian Cancer
(13)
Chemotherapy
(12)
Aged
(11)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(11)
Tumor Cells, Cultured
(11)
Cisplatin - Pharmacology
(10)
Male
(10)
Drug Resistance, Neoplasm
(9)
Gynecology. Andrology. Obstetrics
(9)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label trial

Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial

Indoleamine 2,3-Dioxygenase Serves as a Marker of Poor Prognosis in Gene Expression Profiles of Serous Ovarian Cancer Cells

Adjuvant therapy after radical surgery for stage IB-IIB cervical adenocarcinoma with risk factors

Readministration of Platinum Agents in Recurrent Ovarian Cancer Patients Who Developed Hypersensitivity Reactions to Carboplatin

Retrospective analysis of sites of recurrence in stage I epithelial ovarian cancer

Establishment and characterization of a clear cell carcinoma cell line, designated NOCC, derived from human ovary

Possible involvement of glycolipids in anticancer drug resistance of human ovarian serous carcinoma-derived cells

Side population is increased in paclitaxel-resistant ovarian cancer cell lines regardless of resistance to cisplatin

Alpha-fetoprotein (AFP)-producing ovarian tumor in an elderly woman

Pathology-oriented treatment strategy of malignant ovarian tumor in pregnant women: analysis of 41 cases in Japan

Analysis of prognostic factors for patients with leiomyoma treated with uterine arterial embolization

Randomized Phase III Trial of Irinotecan Plus Cisplatin Compared With Paclitaxel Plus Carboplatin As First-Line Chemotherapy for Ovarian Clear Cell Carcinoma: JGOG3017/GCIG Trial

Characterization of two independent, exposure-time dependent paclitaxel-resistant human ovarian carcinoma cell lines

Small cell carcinoma of the ovary: clinical and biological study

Differential regulation of the cytotoxicity activity of paclitaxel by orobol and platelet derived growth factor in human ovarian carcinoma cells

Favourable Prognosis with Modified Dosing of Docetaxel and Cisplatin in Japanese Patients with Ovarian Cancer

Mithramycin Represses MDR1 Gene Expression in Vitro, Modulating Multidrug Resistance

Two cases of epidural anesthesia‐associated postoperative decubitus

Primary chemotherapy-associated effect of second-line chemotherapy on survival of patients with advanced ovarian cancer

Malignant Struma Ovarii With a Predominant Component of Anaplastic Carcinoma

Progression-free survival by local investigator versus independent central review: Comparative analysis of the AGO-OVAR16 Trial

A Novel Gene, CRR9, Which Was Up-Regulated in CDDP-Resistant Ovarian Tumor Cell Line, Was Associated with Apoptosis

Short-Term Serum Deprivation Confers Sensitivity to Taxanes in Platinum-Resistant Human Ovarian Cancer Cells

Success rate and safety of tumor debulking with diaphragmatic surgery for advanced epithelial ovarian cancer and peritoneal cancer

Aktive Filter

Suchergebnisse filtern